BRIEF-Cadila Healthcare Gets Warning Letter Issued By US FDA Relating To Moraiya Formulation Facility - Reuters
04-Nov-2019 02:36:01 PM
Nov 4 (Reuters) - Cadila Healthcare Ltd CADI.NS:
. - WARNING LETTER - US FDA
SAYS COMPANY HAS RECEIVED A WARNING LETTER ISSUED BY US FDA RELATING TO ITS MORAIYA FORMULATION FACILITY.
WARNING LETTER RELATING TO ITS MORAIYA FORMULATION FACILITY
WILL CONTINUE TO TAKE NECESSARY STEPS TO ENSURE THAT US FDA IS FULLY SATISFIED WITH REMEDIATION OF ABOVE FACILITY
CONFIDENT OF RESPONDING TO US FDA TO ADDRESS THE OBSERVATIONS WITHIN THE STATUTORY TIME
CADILA HEALTHCARE -WARNING LETTER DOES NOT AFFECT EXISTING BUSINESS OF CO IN US AND THE EXISTING PRODUCT SUPPLIES FROM MORAIYA FACILITY TO CONTINUE.